Search

Search Constraints

You searched for: Date 2015 Author/Creator Maines, Francesca

Search Results

3. Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients. (November 2015)

4. Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients. (November 2015)

5. Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients. (March 2015)

6. Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients. (March 2015)

7. Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients. (March 2015)

8. Metabolic syndrome in castration‐resistant prostate cancer patients treated with abiraterone. Issue 12 (15th May 2015)

9. Prognostic and predictive factors in patients treated with chemotherapy for advanced urothelial cancer: where do we stand?. (January 2015)

10. Prognostic and predictive factors in patients treated with chemotherapy for advanced urothelial cancer: where do we stand?. (January 2015)